German pharmaceutical company DEGUSSA has sold its gelatine business (turnover EUR 250 million in 2000 with a staff of 1,485) to the Dutch company SOBEL for EUR 265 million in line with their new strategic orientation of its main business activities. DEGUSSA activity in the gelatine sector represents around 18% of world production.